Featured Research

from universities, journals, and other organizations

Molecule 968 binds glutaminase and starves cancer cells

Date:
September 19, 2010
Source:
Cornell University
Summary:
A molecule -- simply called 968 -- can starve cancer cells and the tumors they produce, says new research. The key to this research is the amino acid glutamine. Researchers have long believed that starving cancer cells of glutamine, which cancer cells require in larger quantities than normal cells, would help fight some cancers. Now, they have discovered a molecule that does the job: Dubbed 968 by investigators, this proof of concept molecule binds to the enzyme glutaminase to inhibit cancer growth by blocking the cancer cells' utilization of glutamine.

A molecule -- simply called 968 -- can starve cancer cells and the tumors they produce, says new research published by Cornell University researchers in the Colleges of Veterinary Medicine and Arts and Sciences.

The key to this research is the amino acid glutamine. Researchers have long believed that starving cancer cells of glutamine, which cancer cells require in larger quantities than normal cells, would help fight some cancers. Now, they have discovered a molecule that does the job: Dubbed 968 by investigators, this proof of concept molecule binds to the enzyme glutaminase to inhibit cancer growth by blocking the cancer cells' utilization of glutamine.

Cancer cells demand a tremendous amount of energy, says Richard Cerione, the Goldwin Smith Professor of Pharmacology and Chemical biology. The finding could lead to a new class of drugs, capable of halting cancer progression without harming normal cell growth, he said.

After discovering that 968 inhibited glutaminase and effectively shrunk tumor cells, Cerione and his research team tested the molecule to understand its effects on non-cancerous cells.

"We have effectively stopped the growth of breast cancer cells in the lab without affecting normal mammary cells," said Cerione, who is now investigating the impact of 968 on other forms of cancer, including prostate, ovarian and pancreatic cell lines. "We've validated our target. The next step will be to further the development of a classes of small molecules capable of stopping cancer cell growth in humans." To that end, Cerione and colleagues are currently working with the KensaGroup, of Ithaca, N.Y., in addition to Cerione's academic pursuits exploring the effects of 968 and glutaminase on cancer cell growth.

"Our research has highlighted a previously unrecognized connection between the cell's metabolic machinery and the signaling pathways and growth factor receptors that regulate cell growth," said Cerione. He believes there is a broader connection between metabolism and cell signaling for other areas in biology and biomedicine.

Cornell co-authors of the research include postdoctoral associate Jianbin Wang (co-first author), and senior research associates Jon Erickson (co-first author), Kristin Wilson and Sekar Ramachandran. Funding for the research: The National Institutes of Health and the Susan G. Komen Foundation.


Story Source:

The above story is based on materials provided by Cornell University. The original article was written by Stephanie Specchio. Note: Materials may be edited for content and length.


Journal Reference:

  1. Wang et al. Targeting Mitochondrial Glutaminase Activity Inhibits Oncogenic Transformation. Cancer Cell, 2010; 18 (3): 207 DOI: 10.1016/j.ccr.2010.08.009

Cite This Page:

Cornell University. "Molecule 968 binds glutaminase and starves cancer cells." ScienceDaily. ScienceDaily, 19 September 2010. <www.sciencedaily.com/releases/2010/09/100918213450.htm>.
Cornell University. (2010, September 19). Molecule 968 binds glutaminase and starves cancer cells. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/2010/09/100918213450.htm
Cornell University. "Molecule 968 binds glutaminase and starves cancer cells." ScienceDaily. www.sciencedaily.com/releases/2010/09/100918213450.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Nigeria Ups Ebola Stakes on 1st Death

Nigeria Ups Ebola Stakes on 1st Death

Reuters - Business Video Online (July 29, 2014) Nigerian authorities have shut and quarantined a Lagos hospital where a Liberian man died of the Ebola virus, the first recorded case of the highly-infectious disease in Africa's most populous economy. David Pollard reports Video provided by Reuters
Powered by NewsLook.com
Running 5 Minutes A Day Might Add Years To Your Life

Running 5 Minutes A Day Might Add Years To Your Life

Newsy (July 29, 2014) According to a new study, just five minutes of running or jogging a day could add years to your life. Video provided by Newsy
Powered by NewsLook.com
Ebola Outbreak Poses Little Threat To U.S.: CDC

Ebola Outbreak Poses Little Threat To U.S.: CDC

Newsy (July 29, 2014) The Ebola outbreak in West Africa poses little threat to Americans, according to officials with the Centers for Disease Control and Prevention. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins